Arama Sonuçları - Emily Labriola–Tompkins

  • Gösterilen 1 - 4 sonuçlar arası kayıtlar. 4
Sonuçları Daraltın
  1. 1
    Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.

    Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor. Yazar: Emily Labriola–Tompkins, Chitra Chandran, K L Kaffka, Denise Biondi, Bradford Graves, Marcos Hatada, Vincent Madison, Jennifer L. Karas, P L Kilian, Ju Gao

    Baskı/Yayın Bilgisi 1991
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.

    Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Yazar: G Ju, Emily Labriola–Tompkins, Carolyn A. Campen, W R Benjamin, Jennifer L. Karas, J Plocinski, Denise Biondi, K L Kaffka, P L Kilian, Stephen P. Eisenberg

    Baskı/Yayın Bilgisi 1991
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma

    A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma Yazar: Geoffrey I. Shapiro, Patricia LoRusso, Afshin Dowlati, T. Khanh, Caron A. Jacobson, Ulka N. Vaishampayan, Amy Weise, Paolo F. Caimi, Joseph P. Eder, Christopher A. French, Emily Labriola–Tompkins, Frédéric Boisserie, William E. Pierceall, Jianguo Zhi, Sharon Passe, Mark DeMario, Martin Kornacker, Philippe Armand

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial

    Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial Yazar: Sumathi Sivapalasingam, David J. Lederer, Rafia Bhore, Negin Hajizadeh, Gerard J. Criner, Romana Hosain, Adnan Mahmood, Angeliki Giannelou, Selin Somersan-Karakaya, Meagan P. O’Brien, Anita Boyapati, Janie Parrino, Bret J. Musser, Emily Labriola–Tompkins, Divya Ramesh, Lisa A. Purcell, Daya Gulabani, Wendy Kampman, Alpana Waldron, Michelle N. Gong, Suraj Saggar, Steven J. Sperber, Vidya Menon, David Stein, Magdalena E. Sobieszczyk, William Park, Judith A. Aberg, Samuel M. Brown, Jack A. Kosmicki, Julie Horowitz, Manuel A. R. Ferreira, Aris Baras, Bari Kowal, A. Thomas DiCioccio, Bolanle Akinlade, Michael C. Nivens, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: